ArticleFrontiers in pharmacology2021

Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials.

Rodolfo Pedro Rothlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.